[Toxocara canis encephalitis: case report].
Mrissa
R
R
Battikh
R
R
Ben Abdelhafidh
N
N
Jemli
B
B
Azzouz
O
O
Zaouali
J
J
Louzir
B
B
M'sadek
F
F
Ben Abdallah
N
N
Gargouri
S
S
Yedeas
M
M
Othmani
S
S
D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004660:Encephalitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D017166:Toxocara canis; D014120:Toxocariasis / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
D000871:Anthelmintics; D000893:Anti-Inflammatory Agents; D015766:Albendazole; D011241:Prednisone